About 4 million fatalities in China annually are credited to heart disease, states Novo Nordisk.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/novo-nordisks-wegovy-approved-for-cardiovascular-disease-treatment-in-china/
Novo Nordisk’s Wegovy approved for cardiovascular disease treatment in China
赞 (0)
关于作者
Danish-developed psoriasis treatment receives Canadian approval
上一篇
25 12 月, 2025 10:18 下午
Novo Nordisk receives US approval for Wegovy tablet
下一篇
25 12 月, 2025 10:18 下午
相关推荐
-
How to lead marketing through economic uncertainty
Advertising in a decline really feels disorderly. However it does not need to. Lisa Cole shares just how to gain back control with audits, AI and vibrant GTM relocations.The blog p…
-
Study: Stars travel more slowly at Milky Way’s edge
By clocking the rate of celebrities throughout the Galaxy galaxy, MIT physicists have actually located that celebrities additionally out in the stellar disk are taking a trip extra…
-
Purdue University develops solar-powered runway surveillance
Researchers from the Purdue Polytechnic Institute in the US have developed a solar-powered surveillance system designed to enhance airport runway safety. The post Purdue University…
-
NTT DOCOMO GLOBAL and Accenture Launch Universal Wallet Infrastructure, Powering the Trusted Future of a Data-Led, AI-Driven Digital Society
NTT DOCOMO GLOBAL and Accenture (NYSE: ACN) are collaborating to establish and scale the Universal Pocketbook Facilities (UWI), a groundbreaking system made to provide enterprise-g…
-
GDPR & EU AI Act: A 2025 checklist for teams who transcribe customer calls (Sponsored)
By 2025, groups that transcribe customer calls encounter greater than simply a functional job. They encounter lawful and moral obligations. Both the GDPR and the EU AI Act form exa…
